Abstract
Estrogen receptor (ESR1) mutations have emerged as a key factor in endocrine therapy resistance. We identified and validated five novel, immunogenic ESR1-derived peptides that could be targeted through vaccine-based immunotherapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have